Motorola Solutions Inc. Stock Rises Monday, Still Underperforms Market

Xilio Therapeutics Inc

Change company Symbol lookup

Select an option...

XLO Xilio Therapeutics Inc

ORN Orion Group Holdings Inc

SMHI SEACOR Marine Holdings Inc

ASC Ardmore Shipping Corp

CCBC Chino Commercial Bancorp

INGR Ingredion Inc

PROF Profound Medical Corp

VWAGY Volkswagen AG

MLVF Malvern Bancorp Inc

GBCI Glacier Bancorp Inc

Company profile

Xilio Therapeutics, Inc. is a biotechnology company. The Company is focused on harnessing the immune system to achieve clinical responses for cancer patients. It offers a geographically precise solutions (GPS) platform to engineer molecules, including cytokines and other biologics, that are designed to enhance therapeutic index. Using its GPS platform, the Company is engaged in developing a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. Its product candidates include XTX101, XTX202, XTX301, and XTX401. XTX101 is a clinical-stage, tumor-selective anti-cytotoxic T-lymphocyte-associated protein (CTLA-4), monoclonal antibody (mAb), which is designed to improve upon the therapeutic index of existing anti-CTLA-4 therapies. XTX202 and XTX301 are an engineered form of interleukin 2 (IL-2) that is masked with a protein domain to prevent binding activity until the protein domain is cleaved off by tumor microenvironment (TME)-associated proteases.

Motorola Solutions Inc. Stock Rises Monday, Still Underperforms Market

5:09 pm ET April 25, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Motorola Solutions Inc. (MSI) inched 0.05% higher to $225.05 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.57% to 4,296.12 and the Dow Jones Industrial Average rising 0.70% to 34,049.46. The stock's rise snapped a two-day losing streak. Motorola Solutions Inc. closed $48.60 below its 52-week high ($273.65), which the company reached on December 30th.

The stock outperformed some of its competitors Monday, as L3Harris Technologies Inc. (LHX) fell 2.00% to $242.92. Trading volume (768,524) remained 180,239 below its 50-day average volume of 948,763.

Data source: Dow Jones Market Data, FactSet. Data compiled April 25, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

April 25, 2022 17:09 ET (21:09 GMT)